RxDoctor Payments Data

Amanda Kimbler, APRN

Family · Mayfield, KYNPI 1174864516

Payments from drug & device makers

$758in general payments, 2019–2025

Across 48 payments — averaging $15.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$279
  • Novo Nordisk$100
  • Lilly USA, LLC$88
  • Amgen$32
  • GSK$29
  • Pfizer$28
  • plus $201 from 13 others

What the payments were for

  • Food & beverage$758100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$758 in reported general payments places this provider in the 55th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$50,272
Medicare patients
381
Services billed
1,552

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide76$91,462
JardianceEmpagliflozin59$55,726
EliquisApixaban57$47,079
JanuviaSitagliptin Phosphate24$26,574
XareltoRivaroxaban20$22,001
TrulicityDulaglutide11$15,555
MyrbetriqMirabegron20$15,159
FarxigaDapagliflozin Propanediol13$11,786
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,117
Tresiba Flextouch U-100Insulin Degludec13$4,971
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$2,972
SymbicortBudesonide/Formoterol Fumarate11$2,880
Atorvastatin Calcium235$1,806
Levocetirizine Dihydrochloride115$1,786
Potassium Chloride106$1,711

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$100$91,46276 claims
PfizerEliquis$28$47,07957 claims
Lilly USA, LLCTrulicity$88$15,55511 claims
Astellas Pharma US IncMyrbetriq$18$15,15920 claims
AstraZenecaFarxiga, Symbicort$13$14,66624 claims
GSKTrelegy Ellipta$29$7,11711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,374 family providers in Kentucky.

Other family in Mayfield

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →